Literature DB >> 15202160

Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndrome.

Aru Narendran1, Lindsay M Hawkins, Hooman Ganjavi, Wilma Vanek, Matthew F Gee, Jason W Barlow, Grant Johnson, David Malkin, Melvin H Freedman.   

Abstract

The development of myeloid leukemias and myelodysplastic syndrome (MDS) is common in children with trisomy 8 mosaicism. However, the mechanisms by which the presence of an additional chromosome 8 translates to an increased risk of leukemias and MDS is currently unknown. The authors describe the analysis of stromal cells from a pediatric MDS patient with constitutional trisomy 8. Patient and control marrow stromal cells were analyzed for alterations in cytokine production. Clonogenic assays were used to examine stromal support for hematopoiesis. The interplay between leukemia cells and stroma was studied by co-culture experiments. The results indicate that stromal cell function in this patient was seriously altered in favor of progenitor cell proliferation and expansion. This indicates that constitutional trisomy 8 in stromal cells plays a critical role in the pathogenesis of MDS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15202160     DOI: 10.1080/08880010490276917

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  8 in total

1.  Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report.

Authors:  Barbara C Engel; Greg M Podsakoff; Joanna L Ireland; E Monika Smogorzewska; Denise A Carbonaro; Kathy Wilson; Ami Shah; Neena Kapoor; Mirna Sweeney; Mark Borchert; Gay M Crooks; Kenneth I Weinberg; Robertson Parkman; Howard M Rosenblatt; Shi-Qi Wu; Michael S Hershfield; Fabio Candotti; Donald B Kohn
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

Review 2.  Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.

Authors:  Joseph Lasky; Kathleen M Sakamoto
Journal:  MedGenMed       Date:  2005-03-14

3.  Somatically acquired mutations in primary myelofibrosis: A case report and meta-analysis.

Authors:  Yongming Xia; Qingxiao Hong; Zhibin Gao; Shijun Wang; Shiwei Duan
Journal:  Exp Ther Med       Date:  2021-01-07       Impact factor: 2.447

4.  Myeloid malignancies and the microenvironment.

Authors:  Claudia Korn; Simón Méndez-Ferrer
Journal:  Blood       Date:  2016-11-15       Impact factor: 22.113

Review 5.  Constitutional aneuploidy and cancer predisposition.

Authors:  Ithamar Ganmore; Gil Smooha; Shai Izraeli
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

6.  Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality.

Authors:  Noelle V Frey; Christopher E Leid; Peter C Nowell; Ewa Tomczak; Honore T Strauser; Margaret Kasner; Steven Goldstein; Alison Loren; Edward Stadtmauer; Selina Luger; Elizabeth Hexner; Joanne Hinkle; David L Porter
Journal:  Am J Hematol       Date:  2008-11       Impact factor: 10.047

7.  Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment.

Authors:  Tony Navas; Li Zhou; Myka Estes; Edwin Haghnazari; Aaron N Nguyen; Yongkai Mo; Perry Pahanish; Mani Mohindru; Tim Cao; Linda S Higgins; Leonidas C Platanias; Alan List; Amit Verma; T Bhagat; S Gajavelli; S Kambhampati
Journal:  Leuk Lymphoma       Date:  2008-10

8.  Warkany syndrome: a rare case report.

Authors:  Amit Agrawal; Rashmi Agrawal
Journal:  Case Rep Pediatr       Date:  2011-10-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.